Keyphrases
Meta-analysis
100%
Systematic Meta-analysis
94%
Erectile Dysfunction
40%
Global Practice
25%
Confidence Interval
24%
Bladder
23%
Urodynamics
22%
Practice Patterns
18%
Survey of Practice
16%
Male Sexual Dysfunction
16%
Minipig
16%
Bladder Pressure Measurement
16%
Tubularized Incised Plate Urethroplasty
16%
Expert Recommendation
16%
Non-obstructive Azoospermia
16%
Randomized Controlled Trial
16%
Odds Ratio
15%
Erectile Function
14%
Varicocele
14%
PubMed
13%
Varicocele Repair
12%
Ureterolithotomy
12%
Reporting Item
12%
Cavernous Nerve Injury
11%
Stem Cells
11%
Bladder Wall
11%
ScienceDirect
11%
Extracorporeal Shock Wave Lithotripsy
11%
Postoperative Complications
10%
Cochrane
10%
Pain Reduction
10%
Global Survey
9%
Peyronie's Disease
8%
No Significant Difference
8%
Prospero
8%
Scopus
8%
Human Corpus Cavernosum
8%
CXCL9
8%
Test Interpretation
8%
Yohimbine
8%
Outcome Comparison
8%
Kidney Stones
8%
Comparative Safety
8%
Retrograde Intrarenal Surgery
8%
Real-life Data
8%
Implantable Pressure Sensor
8%
Mirabegron
8%
Submucosal
8%
Bladder Monitoring
8%
Neurogenic Bladder
8%
Medicine and Dentistry
Meta-Analysis
84%
Systematic Review
77%
Bladder
30%
Erectile Dysfunction
30%
Urodynamics
22%
Randomized Controlled Trial
21%
Azoospermia
18%
Ureter Stone
16%
Hypospadias
16%
Urethroplasty
16%
Surgery
16%
Stem Cell
16%
Kidney Stone
14%
Micturition
12%
Bladder Wall
12%
Peyronie's Disease
12%
In Vitro
11%
Nerve Injury
11%
Bladder Stone
11%
Accelerometer
10%
Odds Ratio
10%
Urology
10%
Postoperative Complication
9%
Urination
9%
Bladder Disease
9%
Intracavernous Injection
8%
Corpus Cavernosum Penis
8%
Placebo
8%
Andrology
8%
Clinical Trial
8%
Lidocaine
8%
Kidney Fibrosis
8%
Ureter Obstruction
8%
Nitrergic Nerve
8%
Galanin
8%
Silodosin
8%
Ureterolithotomy
8%
Varicocele
8%
Percutaneous Nephrolithotomy
8%
Reconstructive Urology
8%
Alpha Adrenergic Receptor Blocking Agent
8%
Semen Analysis
8%
Cystometry
8%
Glycosaminoglycan
8%
Foreign Body
8%
Male Infertility
8%
Penis Injury
8%
Prostate Hypertrophy
8%
Urinary System
8%
Urolithiasis
8%